Search
for
Sort by
Research 271–300 of 1000+
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Hutchinson-gilford progeria syndrome and its relevance to cardiovascular diseases and normal aging.
- Cardiovascular Safety and Benefits of Testosterone Implant Therapy in Postmenopausal Women: Where Are We?
- Cardiovascular risk markers in premature canities
- Cardiovascular risk in women with premature ovarian insufficiency compared to premenopausal women at middle age
- Low dose oral minoxidil and the conundrum of cardiovascular complications
- Cardiac and Medullary Neuroinflammatory Pathways Trigger Androgenic Incitement of Cardiovascular Sequels of Endotoxemia in Rats
- CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS
- Comments on “ Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study ”
- No Increased Cardiovascular Hazard with Oral 5-Alpha-Reductase Inhibitors in Treatment of Androgenetic Alopecia: A TriNetX Retrospective Cohort Study
- Association between androgenetic alopecia and cardiovascular diseases: a genetic correlation and Mendelian randomization study
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Early androgenetic alopecia as a possible indicator of diabetes mellitus and its link to cardiovascular risks: a cross-sectional study
- Cardiovascular and Metabolic Risk Profiles Across Different Phenotypes of Polycystic Ovary Syndrome
- Prevalence of Metabolic Syndrome and Cardiovascular Risk Factors in Early Onset Male Androgenetic Alopecia - A Cross Sectional Study in a Tertiary Care Hospital
- Supplementary file 2_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- Supplementary file 1_Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis.docx
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- Cardiovascular Risks in Women with Polycystic Ovary Syndrome (PCOS): A Narrative Review
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Effect of High Levels of Testosterone on Cardiovascular Risk in Polycystic Ovary Syndrome (PCOS)
- KATP Channels in Zebrafish Cardiovascular System: A Model to Study Cantú Syndrome
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- The Princeton III Consensus Recommendations for the Management of Erectile Dysfunction and Cardiovascular Disease
- Circulating and/or cutaneous irisin resistance: A novel link among androgenetic alopecia, comorbid metabolic syndrome and cardiovascular risks
- RELATİONSHİP BETWEEN ANDROGENETİC ALOPECİA AND CARDİOVASCULAR COMORBİDİTY MARKERS İN WOMEN
- A Study on Association between Androgenetic Alopecia and Cardiovascular Risk Factors in Males with History of Hair Fall